TNF profiles in ovarian cancer and their response to anticancer therapy

被引：0
|
作者：
Volodko, N [1 ]
Oleksyak, O [1 ]
Barylka, V [1 ]
Piddubnyak, V [1 ]
Bilynsky, B [1 ]
机构：
[1] Med Univ, Dept Oncol & Medradiol, Lviv, Ukraine
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81388-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
968
引用
收藏
页码：S244 / S245
页数：2
相关论文
共 50 条
  • [21] SERUM LIPID PROFILES IN OVARIAN CANCER
    Lv, Q.
    Xiaojun, C.
    Congjian, X.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 759 - 759
  • [22] Combination chemotherapy photodynamic therapy with HPMA copolymer-bound anticancer drugs for ovarian cancer
    Peterson, CM
    Lu, JM
    Sun, Y
    Peterson, CA
    Shiah, JG
    Straight, RC
    Kopecek, J
    23RD INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, 1996 PROCEEDINGS, 1996, : 109 - 110
  • [23] Role of miRNAs in the response to anticancer therapy
    Frampton, Adam L.
    Krell, Jonathan
    Giovannetti, Elisa
    Jiao, Long R.
    Stebbing, Justin
    PHARMACOGENOMICS, 2012, 13 (15) : 1663 - 1666
  • [24] Tumor microenvironment and the response to anticancer therapy
    Brown, JM
    CANCER BIOLOGY & THERAPY, 2002, 1 (05) : 453 - 458
  • [25] Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer
    Sims, A. H.
    Zweemer, A. J. M.
    Nagumo, Y.
    Faratian, D.
    Muir, M.
    Dodds, M.
    Um, I.
    Kay, C.
    Hasmann, M.
    Harrison, D. J.
    Langdon, S. P.
    BRITISH JOURNAL OF CANCER, 2012, 106 (11) : 1779 - 1789
  • [26] Clinical Predictors of Response to Palliative Radiation Therapy for Recurrent Ovarian Cancer
    Jiang, G.
    Balboni, T. A.
    Taylor, A.
    Viswanathan, A. N.
    Lee, L. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E269 - E270
  • [27] Estrogen receptor beta and ovarian cancer: a key to pathogenesis and response to therapy
    Kyriakidis, Ioannis
    Papaioannidou, Paraskevi
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (06) : 1161 - 1168
  • [28] Estrogen receptor beta and ovarian cancer: a key to pathogenesis and response to therapy
    Ioannis Kyriakidis
    Paraskevi Papaioannidou
    Archives of Gynecology and Obstetrics, 2016, 293 : 1161 - 1168
  • [29] CORRELATION OF HISTOLOGIC GRADE WITH SURVIVAL AND RESPONSE TO THERAPY IN EPITHELIAL OVARIAN CANCER
    OZOLS, RF
    GARVIN, AJ
    COSTA, J
    YOUNG, RC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 393 - 393
  • [30] Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer
    A H Sims
    A JM Zweemer
    Y Nagumo
    D Faratian
    M Muir
    M Dodds
    I Um
    C Kay
    M Hasmann
    D J Harrison
    S P Langdon
    British Journal of Cancer, 2012, 106 : 1779 - 1789
12345